BIORELIANCE CORP
10-Q, EX-27, 2000-08-14
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: BIORELIANCE CORP, 10-Q, 2000-08-14
Next: ROCKDALE NATIONAL BANCSHARES INC, 10QSB, 2000-08-14



<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM 2ND QUARTER
2000 FORM 10-Q UNAUDITED CONSOLIDATED BALANCE SHEETS AND UNAUDITED CONSOLIDATED
STATEMENTS OF OPERATIONS AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH
FORM 10Q
</LEGEND>
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          11,424
<SECURITIES>                                     6,458
<RECEIVABLES>                                   19,980
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                                40,009
<PP&E>                                          39,650
<DEPRECIATION>                                       0
<TOTAL-ASSETS>                                  80,392
<CURRENT-LIABILITIES>                           15,395
<BONDS>                                              0
                                0
                                          0
<COMMON>                                            81
<OTHER-SE>                                      52,910
<TOTAL-LIABILITY-AND-EQUITY>                    80,392
<SALES>                                         27,252
<TOTAL-REVENUES>                                27,252
<CGS>                                           17,796
<TOTAL-COSTS>                                   17,796
<OTHER-EXPENSES>                                 8,666
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 412
<INCOME-PRETAX>                                    787
<INCOME-TAX>                                       331
<INCOME-CONTINUING>                                456
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                       456
<EPS-BASIC>                                        .06
<EPS-DILUTED>                                      .06


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission